Literature DB >> 15355854

The molecular basis of skeletal muscle atrophy.

Robert W Jackman1, Susan C Kandarian.   

Abstract

Skeletal muscle atrophy attributable to muscular inactivity has significant adverse functional consequences. While the initiating physiological event leading to atrophy seems to be the loss of muscle tension and a good deal of the physiology of muscle atrophy has been characterized, little is known about the triggers or the molecular signaling events underlying this process. Decreases in protein synthesis and increases in protein degradation both have been shown to contribute to muscle protein loss due to disuse, and recent work has delineated elements of both synthetic and proteolytic processes underlying muscle atrophy. It is also becoming evident that interactions among known proteolytic pathways (ubiquitin-proteasome, lysosomal, and calpain) are involved in muscle proteolysis during atrophy. Factors such as TNF-alpha, glucocorticoids, myostatin, and reactive oxygen species can induce muscle protein loss under specified conditions. Also, it is now apparent that the transcription factor NF-kappaB is a key intracellular signal transducer in disuse atrophy. Transcriptional profiles of atrophying muscle show both up- and downregulation of various genes over time, thus providing further evidence that there are multiple concurrent processes involved in muscle atrophy. The purpose of this review is to synthesize our current understanding of the molecular regulation of muscle atrophy. We also discuss how ongoing work should uncover more about the molecular underpinnings of muscle wasting, particularly that due to disuse.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Substances:

Year:  2004        PMID: 15355854     DOI: 10.1152/ajpcell.00579.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  293 in total

1.  Maternal protein restriction induce skeletal muscle changes without altering the MRFs MyoD and myogenin expression in offspring.

Authors:  Ludimila Canuto Cabeço; Paulo Eduardo Budri; Mirella Baroni; Eduardo Paulino Castan; Fernanda Regina Carani; Paula Aiello Tomé de Souza; Patrícia Aline Boer; Selma Maria Michelin Matheus; Maeli Dal-Pai-Silva
Journal:  J Mol Histol       Date:  2012-04-27       Impact factor: 2.611

2.  Salmonid genomes have a remarkably expanded akirin family, coexpressed with genes from conserved pathways governing skeletal muscle growth and catabolism.

Authors:  Daniel J Macqueen; Bjarni K Kristjánsson; Ian A Johnston
Journal:  Physiol Genomics       Date:  2010-04-13       Impact factor: 3.107

Review 3.  The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?

Authors:  T van Wessel; A de Haan; W J van der Laarse; R T Jaspers
Journal:  Eur J Appl Physiol       Date:  2010-07-03       Impact factor: 3.078

Review 4.  Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?

Authors:  Marios Panagiotou; Andrew J Peacock; Martin K Johnson
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

Review 5.  Respiratory and lower limb muscle function in interstitial lung disease.

Authors:  Marios Panagiotou; Vlasis Polychronopoulos; Charlie Strange
Journal:  Chron Respir Dis       Date:  2016-01-14       Impact factor: 2.444

6.  Inhibition of the ubiquitin-proteasome pathway does not protect against ventilator-induced accelerated proteolysis or atrophy in the diaphragm.

Authors:  Ashley J Smuder; W Bradley Nelson; Matthew B Hudson; Andreas N Kavazis; Scott K Powers
Journal:  Anesthesiology       Date:  2014-07       Impact factor: 7.892

7.  The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscle.

Authors:  Marjan M Tajrishi; Shuichi Sato; Jonghyun Shin; Timothy S Zheng; Linda C Burkly; Ashok Kumar
Journal:  Biochem Biophys Res Commun       Date:  2014-03-26       Impact factor: 3.575

8.  Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.

Authors:  Sajedah M Hindi; Vivek Mishra; Shephali Bhatnagar; Marjan M Tajrishi; Yuji Ogura; Zhen Yan; Linda C Burkly; Timothy S Zheng; Ashok Kumar
Journal:  FASEB J       Date:  2013-12-10       Impact factor: 5.191

9.  Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency.

Authors:  Francisca Diaz; Christine K Thomas; Sofia Garcia; Dayami Hernandez; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2005-08-15       Impact factor: 6.150

10.  Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens.

Authors:  Richard R Almon; Debra C DuBois; Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; William J Jusko
Journal:  Physiol Genomics       Date:  2007-05-01       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.